The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas
- PMID: 26649588
- PMCID: PMC4882269
- DOI: 10.1097/SLA.0000000000001364
The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas
Abstract
Objectives: Our study aims at producing acellular extracellular matrix scaffolds from the human pancreas (hpaECMs) as a first critical step toward the production of a new-generation, fully human-derived bioartificial endocrine pancreas. In this bioartificial endocrine pancreas, the hardware will be represented by hpaECMs, whereas the software will consist in the cellular compartment generated from patient's own cells.
Background: Extracellular matrix (ECM)-based scaffolds obtained through the decellularization of native organs have become the favored platform in the field of complex organ bioengineering. However, the paradigm is now switching from the porcine to the human model.
Methods: To achieve our goal, human pancreata were decellularized with Triton-based solution and thoroughly characterized. Primary endpoints were complete cell and DNA clearance, preservation of ECM components, growth factors and stiffness, ability to induce angiogenesis, conservation of the framework of the innate vasculature, and immunogenicity. Secondary endpoint was hpaECMs' ability to sustain growth and function of human islet and human primary pancreatic endothelial cells.
Results: Results show that hpaECMs can be successfully and consistently produced from human pancreata and maintain their innate molecular and spatial framework and stiffness, and vital growth factors. Importantly, hpaECMs inhibit human naïve CD4 T-cell expansion in response to polyclonal stimuli by inducing their apoptosis and promoting their conversion into regulatory T cells. hpaECMs are cytocompatible and supportive of representative pancreatic cell types.
Discussion: We, therefore, conclude that hpaECMs has the potential to become an ideal platform for investigations aiming at the manufacturing of a regenerative medicine-inspired bioartificial endocrine pancreas.
Conflict of interest statement
DISCLOSURE: No conflict of interest to declare by any of the coauthors.
Figures
Similar articles
-
Decellularized pancreas as a native extracellular matrix scaffold for pancreatic islet seeding and culture.J Tissue Eng Regen Med. 2018 May;12(5):1230-1237. doi: 10.1002/term.2655. Epub 2018 Apr 10. J Tissue Eng Regen Med. 2018. PMID: 29499099
-
Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application.FASEB J. 2022 Oct;36(10):e22574. doi: 10.1096/fj.202200807R. FASEB J. 2022. PMID: 36165227
-
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering.Biomaterials. 2013 Jul;34(22):5488-95. doi: 10.1016/j.biomaterials.2013.03.054. Epub 2013 Apr 10. Biomaterials. 2013. PMID: 23583038 Free PMC article.
-
Renal bioengineering with scaffolds generated from human kidneys.Nephron Exp Nephrol. 2014;126(2):119. doi: 10.1159/000360684. Epub 2014 May 19. Nephron Exp Nephrol. 2014. PMID: 24854653 Review.
-
Tissue engineering of decellularized pancreas scaffolds for regenerative medicine in diabetes.Acta Biomater. 2023 Feb;157:49-66. doi: 10.1016/j.actbio.2022.11.032. Epub 2022 Nov 24. Acta Biomater. 2023. PMID: 36427686 Review.
Cited by
-
Unlocking the Promise of Decellularized Pancreatic Tissue: A Novel Approach to Support Angiogenesis in Engineered Tissue.Bioengineering (Basel). 2024 Feb 14;11(2):183. doi: 10.3390/bioengineering11020183. Bioengineering (Basel). 2024. PMID: 38391669 Free PMC article.
-
Development potential of extracellular matrix hydrogels as hemostatic materials.Front Bioeng Biotechnol. 2023 Jun 13;11:1187474. doi: 10.3389/fbioe.2023.1187474. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37383519 Free PMC article. Review.
-
The Canine Pancreatic Extracellular Matrix in Diabetes Mellitus and Pancreatitis: Its Essential Role and Therapeutic Perspective.Animals (Basel). 2023 Feb 15;13(4):684. doi: 10.3390/ani13040684. Animals (Basel). 2023. PMID: 36830471 Free PMC article. Review.
-
Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes.Nat Commun. 2023 Feb 16;14(1):878. doi: 10.1038/s41467-023-36582-1. Nat Commun. 2023. PMID: 36797282 Free PMC article.
-
Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine.Biomater Res. 2023 Feb 9;27(1):10. doi: 10.1186/s40824-023-00348-z. Biomater Res. 2023. PMID: 36759929 Free PMC article. Review.
References
-
- Orlando G, Gianello P, Salvatori M, et al. Cell replacement strategies aiming at reconstitution of the beta cell compartment in type 1 diabetes. Diabetes. 2014;63:1433–1444. - PubMed
-
- Orlando G, Stratta RJ, Light J. Pancreas transplantation for type 2 diabetes mellitus. Curr Op Org Transpl. 2011;16:110–115. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
